ITRM Research and Charts

ITRM - Iterum Therapeutics PLC (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-13 (Delayed quote data 2025-01-03)

Last 1.90	Change ⇑ +0.07 (+3.83%)	Volume 476,044
	Open 1.85	High 1.94	Low 1.81

8EMA (Daily) 1.85	40EMA (Daily) 1.81	50EMA (Daily) 1.76	STO (Daily) 31.824	MACD Hist (Daily) -0.042
8EMA (Weekly) 1.835	40EMA (Weekly) 1.49	50EMA (Weekly) 1.46	STO (Weekly) 55.039	MACD Hist (Weekly) 0.104


Company Profile
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.